Mutation altering the miR-184 seed region causes familial keratoconus with cataract

Anne E Hughes1, Declan T Bradley, Malcolm Campbell

  • 1Centre for Public Health, The Queen's University of Belfast, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BN, Northern Ireland, UK. a.hughes@qub.ac.uk

Insights

A mutation in microRNA-184 (miR-184) causes familial keratoconus and early-onset cataract. This altered miR-184 disrupts gene regulation in the cornea and lens, highlighting miRNA

Area of Science:

  • Genetics and Molecular Biology
  • Ophthalmology
  • Developmental Biology

Background:

  • MicroRNAs (miRNAs) regulate gene expression by binding to messenger RNAs (mRNAs).
  • Dysregulation of miRNA function can lead to various diseases.
  • Familial severe keratoconus and early-onset anterior polar cataract are rare genetic disorders affecting the eye.

Purpose of the Study:

  • To identify the genetic cause of familial severe keratoconus and early-onset anterior polar cataract.
  • To investigate the role of microRNA-184 (miR-184) in the pathogenesis of these eye conditions.
  • To elucidate the molecular mechanisms underlying miRNA-mediated disease development.

Main Methods:

  • Deep sequencing of a linkage region to identify mutations.
  • Analysis of microRNA seed region mutations.
  • Investigation of miRNA target site competition and gene regulation.
  • Assessment of tissue-specific gene expression patterns.

Main Results:

  • A mutation in the seed region of miR-184 was identified as the cause of the observed phenotype.
  • The mutant miR-184 failed to compete with miR-205 for binding sites on INPPL1 and ITGB4 mRNAs.
  • High expression of miR-184 in the cornea and lens restricted the disease phenotype to these tissues.
  • This highlights the tissue specificity of miRNA-regulated gene networks.

Conclusions:

  • Mutations in miR-184 can cause severe ocular diseases, including keratoconus and cataract.
  • Understanding tissue-specific miRNA networks is crucial for disease gene identification and therapeutic target discovery.
  • miRNAs represent potential therapeutic targets for both rare and common diseases affecting the eye.